Creative Medical Technology Holdings, Inc. Current Assets
Creative Medical Technology Holdings, Inc. (CELZ) had Current Assets of $9.02 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-07
- 2026-06-30: Assets, Current $9.02M.
- 2026-03-31: Assets, Current $6.06M.
- 2025-12-31: Assets, Current $7.40M.
- 2025-09-30: Assets, Current $5.41M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $9.02M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $6.06M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $7.40M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $5.41M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $6.63M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $7.84M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $6.14M 10-K · filed 2026-03-20 | |
| 2024-09-30 | $6.33M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $7.60M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $9.20M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $10.27M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $12.04M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $13.73M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $14.81M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $18.75M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $22.01M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $22.95M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $9.23M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $10.74M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $2.58M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $158.59K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $275.13K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $98.01K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $38.71K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $39.62K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $49.53K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $94.25K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $182.74K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $205.11K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $419.64K 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $313.66K 10-K · filed 2020-04-06 | |
| 2018-09-30 | $186.83K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $105.30K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $111.91K 10-Q · filed 2018-08-03 | |
| 2017-12-31 | $18.50K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $21.22K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $104.40K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $98.12K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $221.87K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $33.46K 10-Q · filed 2016-11-10 | |
| 2016-03-31 | $216.00 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $49.60K 10-K · filed 2017-02-13 | $216.00 10-K · filed 2016-04-14 |
| 2015-09-30 | $741.00 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $641.00 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $583.00 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $954.00 10-K · filed 2016-04-14 | |
| 2014-09-30 | $1.29K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $1.29K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $1.29K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $374.00 10-K · filed 2015-02-27 | |
| 2013-09-30 | $398.00 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $403.00 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $1.78K 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $1.57K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $1.15K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $531.00 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $1.63K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $3.10K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $4.21K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $400.00 10-Q/A · filed 2011-08-25 | |
| 2010-12-31 | $414.00 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |